Pulsed Electric Field (PEF) treatment of progressive non-small cell lung cancer concurrently treated with immune checkpoint blockade: A case report
Pulsed Electric Field (PEF) energy was delivered at the time of confirmational biopsy to ablate recurrent NSCLC in the right upper lobe (RUL) of the lung after recurrence while on durvalumab consolidation. The patient tolerated the procedure and exhibited stable disease at 6 and 12 months from time...
Main Authors: | Marcelo Jimenez, Jose M. Fernandez, William S. Krimsky |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-01-01
|
Series: | Respiratory Medicine Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213007124000418 |
Similar Items
-
METHOD FOR STUDY MYOCARDIAL TISSUE IN VITRO: APPLICATION OF NANOSECOND PULSED ELECTRIC FIELDS (nsPEFs)
by: Decebal Vasincu, et al.
Published: (2017-07-01) -
Concepts and Capabilities of In-House Built Nanosecond Pulsed Electric Field (nsPEF) Generators for Electroporation: State of Art
by: Paulius Butkus, et al.
Published: (2020-06-01) -
Treatment Progress of Immune Checkpoint Blockade Therapy for Glioblastoma
by: Na Zhang, et al.
Published: (2020-11-01) -
Affecting Casein Micelles by Pulsed Electrical Field (PEF) for Inclusion of Lipophilic Organic Compounds
by: Dana Middendorf, et al.
Published: (2021-05-01) -
Classification of Non-Small Cell Lung Cancer’s Tumor Immune Micro-Environment and Strategies to Augment Its Response to Immune Checkpoint Blockade
by: Alexander Chi, et al.
Published: (2021-06-01)